Physician profile
John Wayne Wells
NPI 1831119791
$3,279.72
in general payments reported to CMS, 2019-2025
26 companies · $858 in 2025
The $858 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $227 · 2022: $899 · 2023: $729 · 2024: $567 · 2025: $858.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,153.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $887.06 | 2022-2025 | Xience Skypoint, Dragonfly Opstar, Xience Sierra |
| Novartis Pharmaceuticals Corporation | $430.99 | 2022-2025 | |
| Pfizer INC. | $256.79 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $236.20 | 2021-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $231.90 | 2023-2025 | Jardiance |
| Amgen INC. | $210.56 | 2023-2025 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $176.07 | 2021-2025 | Lifevest |
| Novo Nordisk INC | $145.60 | 2022-2025 | Wegovy, Rybelsus, Ozempic |
| Baxter Healthcare | $120.00 | 2024-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Cardiac Ambulatory Monitor |
| Medtronic, INC. | $81.04 | 2021-2025 | Linq II, Tyrx |
| Verona Pharma, INC. | $77.16 | 2025 | Ohtuvayre |
| Regeneron Healthcare Solutions, INC. | $69.01 | 2023-2025 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $54.76 | 2021-2023 | Andexxa |
| Philips North America LLC | $47.82 | 2024-2025 | (9278) Bridge, Ambulatory Monitoring & Diagnostics Undivided |
| Mylan Specialty L.P. | $42.36 | 2023 | Yupelri |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viatris Specialty LLC | $35.52 | 2025 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $31.62 | 2024-2025 | Glassia |
| Bayer Healthcare Pharmaceuticals INC. | $22.20 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $21.89 | 2024 | |
| Abiomed | $20.57 | 2025 | |
| Kestra Medical Technology Services, INC. | $16.45 | 2024 | Assure Wcd |
| Merck Sharp & Dohme LLC | $15.45 | 2023 | Verquvo |
| Glaxosmithkline, LLC. | $14.54 | 2021 | |
| Nestle Healthcare Nutrition INC. | $14.18 | 2023 | |
| Kiniksa Pharmaceuticals, LTD. | $11.99 | 2022 | |
| Vivaquant INC, Dba Rhythm Express | $7.99 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Wells listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.